Pharmaceutical patent linkage system in USA

陈敬,史录文
2012-01-01
Abstract:In this paper, we attempted to explore the legislation and practice of Pharmaceutical Patent Linkage System in USA and assess their legislative shortcomings by literature survey, in order to provide a useful reference for policymakers to build the pharmaceutical patent linkage system in China. In China, the USA system should not be followed blindly, the interests of both innovative and generic pharmaceutical companies should be weighed, and public health interests should be protected. The mechanism to prevent the abuse complaint of originator pharmaceutical companies should be designed properly, and the pharmaceutical patent linkage system suitable for our national conditions should be established.
What problem does this paper attempt to address?